Stock Detail
$CLX
Consumer Defensive · 4 tracked mentions in the last 90 days across 3 creators.
Valuation and creator stance reflect the last 90 days. The mention feed below shows the latest tracked mentions across all history.
CLX leans undervalued across 3 creators and 6 classified valuation claims, with 2 direct claims carrying most of the signal.
Creator Evidence
Why creators say this
Explicit claim • strong conviction • basis: multiple relative
But while the headlines did look a bit ugly for this one, uh I just think that the market is missing a bit of a deep value story here for this stock. ... Valuation is over 40% cheaper than its 5-year average.
Explicit claim • strong conviction • basis: fair value gap
And right now, you can buy Clorox stock at $96 per share. And I calculated its fair value at $140.
Explicit claim • moderate conviction • basis: growth vs multiple
So, for investors with a longer holding period, this might represent a bullish opportunity.
Contextual claim • weak conviction • basis: growth vs multiple
So, based on its sales growth guidance, that implies roughly 835 million to 996 million in free cash flow, which if we jump back over to the dividend breakdown sheet, we can see that would cover their dividend in 2027. But with that being said, the dividend would still be eating up the vast majority of free cash flow.
Mention History
Latest mentions across all history
Feed